- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CEP-701 60mg
Total 6835 results
-
CephalonCompletedPsoriasisUnited States
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityCompleted
-
CephalonCompleted
-
Linda Van EldikNational Institute on Aging (NIA); Duke Clinical Research InstituteCompleted
-
Lee's Pharmaceutical LimitedCompletedPharmacokinetic and Pharmacodynamic Profile of TecarfarinHong Kong
-
CephalonH. Lundbeck A/S; The Parkinson Study GroupTerminatedParkinson DiseaseUnited States, Canada, Puerto Rico
-
MitoImmune TherapeuticsCompletedHeathly SubjectsKorea, Republic of
-
Taisho Pharmaceutical Co., Ltd.CompletedHyperphosphatemia Patients on HemodialysisJapan
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedPsoriasisGermany, Israel, Poland, Spain
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumUnknownPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States
-
CephalonTerminated
-
Maxinovel Pty., Ltd.Not yet recruitingAdvanced / Metastatic Solid Tumors
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDCompletedChronic Hepatitis BChina
-
BeBetter Med IncCompleted
-
Genor Biopharma Co., Ltd.Unknown
-
EnnovaBio Australia Pharmaceuticals Pty LtdCompleted
-
Galera Therapeutics, Inc.Completed
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsTerminatedAtopic DermatitisUnited States, United Kingdom, Germany, Hungary, Russian Federation, Taiwan, Belgium, Netherlands, Japan, Austria, Finland, Slovakia, Czechia, Canada, Iceland, Poland
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Bukwang PharmaceuticalCompletedChronic Hepatitis BKorea, Republic of
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityCompleted
-
Medicines for Malaria VentureUniversity of Cape TownCompleted
-
University of OxfordDepartment of Medical Research, Lower MyanmarCompleted
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Recruiting
-
Anji PharmaCovanceCompletedFunctional ConstipationChina, United States
-
Suzhou Connect Biopharmaceuticals, Ltd.Active, not recruiting
-
International AIDS Vaccine InitiativeBeth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; University of Texas Health, Houston AIDS Research Team (HART) and other collaboratorsCompleted
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Impact Therapeutics, Inc.Not yet recruiting
-
Impact Therapeutics, Inc.Not yet recruiting
-
Shandong New Time Pharmaceutical Co., LTDCompleted
-
New Cancer Cure-Bio Co.,Ltd.RecruitingAdvanced Solid TumorsKorea, Republic of
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, United States, France, Germany, Mexico, Puerto Rico, Peru
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeActive, not recruitingCardiovascular Diseases | AtherosclerosisUnited Kingdom
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
AstraZenecaCompletedScientific Terminology Chronic Obstructive Pulmonary Disease (COPD) | Laymen Terminology Chronic Bronchitis and EmphysemaBulgaria, Germany, Hungary, Ukraine
-
LG Life SciencesCompleted
-
IlDong Pharmaceutical Co LtdCompleted
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingNon-Alcoholic Steatohepatitis (NASH)China
-
Cerenis Therapeutics, SACompleted
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Cerenis Therapeutics, SASouth Australian Health and Medical Research InstituteCompletedAcute Coronary SyndromesUnited States, Australia, Netherlands, Hungary
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Suspended
-
Sharon WalshNational Institute on Drug Abuse (NIDA); Merck Sharp & Dohme LLCCompleted
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Not yet recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisChina